Tag: PBAC
-
One in four new drugs spurn PBS
- 15 Sep 2021
Exclusive analysis of TGA new drug approvals from 2019 and 2020 show many either do not seek PBS listing or withdraw.
Read more -
PBS access ‘built for big pharma’: LEO GM
- 30 Aug 2021
Pharma leader Jason Gavin says navigating pricing, access and reimbursement processes in Australia is challenging for small and mid-sized companies.
Read more -
PBAC rejects third of new drugs
- 23 Aug 2021
Exclusive analysis of the PBAC’s July decisions with insights into how it compared with previous meets and a drill-down into what it means.
Read more -
PBAC early resolution offers flop
- 04 Aug 2021
The PBAC offered the new pathway to two sponsors but with very specific conditions.
Read more -
CF consumers bombard PBAC
- 19 Jul 2021
Thousands wrote in to support the PBS listing of Trikafta. Considered by PBAC three times in four months, did it make a difference?
Read more -
Price a sticking point for PBAC
- 19 Jul 2021
Being fast-tracked to TGA approval does not often guarantee a fast track to funding, as the PBAC’s March meeting outcomes released Friday showed.
Read more -
PBAC appoints new consumer rep
- 09 Jul 2021
A West Australian cancer expert and survivor has replaced Bel Harper as consumer nominee, taking PBAC’s membership to 21.
Read more -
Two score PBS fast track
- 05 Jul 2021
Two companies were offered the costly fast-track to a PBS listing while price has again been revealed as the stumbling block for failed PBAC submissions.
Read more